(Q36773617)

16 August 2017

1 reference

title

Effectiveness of bisphosphonates on bone pain and quality of life in breast cancer patients with metastatic bone disease: a review (English)

1 reference

16 August 2017

1 reference

Ingo J Diel

1

1 reference

16 August 2017

publication date

29 March 2007

1 reference

Supportive Care in Cancer

16 August 2017

published in

1 reference

16 August 2017

volume

15

1 reference

16 August 2017

issue

11

1 reference

16 August 2017

page(s)

1243-1249

1 reference

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

16 August 2017

cites work

1 reference

12 December 2020

Bisphosphonates for breast cancer

1 reference

12 December 2020

Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion

1 reference

12 December 2020

Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group

1 reference

12 December 2020

The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer

1 reference

12 December 2020

Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer

1 reference

12 December 2020

Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer

1 reference

12 December 2020

Effect of oral clodronate on metastatic bone pain: a double-blind, placebo-controlled study

1 reference

12 December 2020

Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis

1 reference

12 December 2020

Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group.

1 reference

12 December 2020

Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group

1 reference

12 December 2020

The symptoms of advanced cancer.

1 reference

12 December 2020

Safety and pain palliation of zoledronic acid in patients with breast cancer, prostate cancer, or multiple myeloma who previously received bisphosphonate therapy

1 reference

12 December 2020

1 reference

12 December 2020

Oral clodronate in breast cancer patients with bone metastases: a randomized study.

1 reference

12 December 2020

Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials

1 reference

12 December 2020

Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration

1 reference

12 December 2020

Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial

1 reference

12 December 2020

Effects of dichloromethylene diphosphonate in women with breast carcinoma metastatic to the skeleton

1 reference

12 December 2020

Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial

1 reference

12 December 2020

Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies

1 reference

12 December 2020

Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial

1 reference

12 December 2020

Pamidronate for pain control in patients with malignant osteolytic bone disease: a prospective dose-effect study

1 reference

12 December 2020

Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer

1 reference

12 December 2020

Efficacy and safety of ibandronate in the treatment of opioid-resistant bone pain associated with metastatic bone disease: a pilot study

1 reference

12 December 2020

Palliative pamidronate treatment in patients with bone metastases from breast cancer

1 reference

12 December 2020

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group

1 reference

12 December 2020

American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer

1 reference

12 December 2020

Treatment of metastatic bone disease in breast cancer: bisphosphonates

1 reference

12 December 2020

Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy

1 reference

12 December 2020

10.1007/S00520-007-0244-9

Identifiers

DOI

1 reference

16 August 2017

1 reference